Anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure

Creative Commons License

Yazar S., Demirtaş F., Yalcin A. A., YAMAN O., Tokgoz B., UTAŞ C., ...More

YONSEI MEDICAL JOURNAL, vol.44, no.2, pp.288-292, 2003 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 2
  • Publication Date: 2003
  • Doi Number: 10.3349/ymj.2003.44.2.288
  • Journal Name: YONSEI MEDICAL JOURNAL
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.288-292
  • Keywords: Toxoplasma gondii, haemodialysis, chronic renal failure, ELISA, INVITRO, UREMIA
  • Erciyes University Affiliated: Yes

Abstract

This study aimed to determine the prevalence of anti-Toxoplasma gondii antibodies in haemodialysis patients with chronic renal failure (CRF). Methods: One hundred and seventy three haemodialysis patients, and 40 healthy controls, were studied for the prevalence of anti-Toxoplasma gondii antibodies by a micro enzyme-linked immunosorbent assay (ELISA). Anti-T gondii IgG antibodies were detected in 97 (56.06%) haemodialysis patients and 8 (20%) controls with a statistical significance. In addition, anti-T. gondii IgM antibodies were detected in 1.73% of patients, but none of the controls. In conclusion, a high percentage of positivity for Toxoplasma antibodies in patients with CRF undergoing haemodialysis was noticed, thus parasitological surveys of CRF patients should be periodically performed to prevent the possible dissemination of toxoplasmosis through the dialysis procedure.